• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

威斯康星糖尿病视网膜病变流行病学研究。第十四部分。糖尿病视网膜病变的十年发病率及进展情况。

The Wisconsin Epidemiologic Study of diabetic retinopathy. XIV. Ten-year incidence and progression of diabetic retinopathy.

作者信息

Klein R, Klein B E, Moss S E, Cruickshanks K J

机构信息

Department of Ophthalmology and Visual Sciences, University of Wisconsin Medical School, Madison.

出版信息

Arch Ophthalmol. 1994 Sep;112(9):1217-28. doi: 10.1001/archopht.1994.01090210105023.

DOI:10.1001/archopht.1994.01090210105023
PMID:7619101
Abstract

OBJECTIVE

To examine the 10-year incidence and progression of diabetic retinopathy.

DESIGN

Population-based incidence study.

PARTICIPANTS

Seven hundred sixty-five insulin-taking diabetic persons diagnosed before age 30 years, 251 insulin-taking diabetic persons diagnosed at age 30 years or older, and 282 non-insulin-taking diabetic persons diagnosed at age 30 years or older who participated in baseline, 4-year, and 10-year follow-up examinations.

MAIN OUTCOME MEASURES

The 10-year incidence of any retinopathy, progression of retinopathy, and progression to proliferative retinopathy were detected by masked grading of stereoscopic color fundus photographs using the modified Airlie House classification and the Early Treatment Diabetic Retinopathy Study severity scheme.

RESULTS

The 10-year incidence of retinopathy (89%, 79%, and 67%), progression of retinopathy (76%, 69%, and 53%), and progression to proliferative retinopathy (30%, 24%, and 10%) were highest in the group diagnosed before age 30 years, intermediate in the insulin-taking group diagnosed at age 30 years or older, and lowest in the non-insulin-taking group, respectively. Increased risk of proliferative retinopathy was associated with more severe retinopathy at baseline.

CONCLUSIONS

These data suggest relatively high 10-year rates of incidence and progression of retinopathy, and despite changes in the treatment of diabetes, there has been little change in the incidence and progression of diabetic retinopathy during the 10-year study period.

摘要

目的

研究糖尿病视网膜病变的10年发病率及病情进展情况。

设计

基于人群的发病率研究。

参与者

765名30岁之前被诊断出的胰岛素依赖型糖尿病患者、251名30岁及以上被诊断出的胰岛素依赖型糖尿病患者以及282名30岁及以上被诊断出的非胰岛素依赖型糖尿病患者,这些患者均参与了基线、4年及10年的随访检查。

主要观察指标

采用改良的艾利屋分类法和糖尿病视网膜病变早期治疗研究严重程度分级方案,通过对立体彩色眼底照片进行盲法分级,检测任何视网膜病变的10年发病率、视网膜病变的进展情况以及进展为增殖性视网膜病变的情况。

结果

视网膜病变的10年发病率(89%、79%和67%)、视网膜病变的进展情况(76%、69%和53%)以及进展为增殖性视网膜病变的比例(30%、24%和10%)在30岁之前被诊断出的患者组中最高,在30岁及以上被诊断出的胰岛素依赖型患者组中处于中间水平,在非胰岛素依赖型患者组中最低。增殖性视网膜病变风险的增加与基线时更严重的视网膜病变相关。

结论

这些数据表明视网膜病变的10年发病率和进展率相对较高,并且尽管糖尿病治疗方法有所改变,但在10年研究期间糖尿病视网膜病变的发病率和进展情况几乎没有变化。

相似文献

1
The Wisconsin Epidemiologic Study of diabetic retinopathy. XIV. Ten-year incidence and progression of diabetic retinopathy.威斯康星糖尿病视网膜病变流行病学研究。第十四部分。糖尿病视网膜病变的十年发病率及进展情况。
Arch Ophthalmol. 1994 Sep;112(9):1217-28. doi: 10.1001/archopht.1994.01090210105023.
2
The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes.威斯康星糖尿病视网膜病变流行病学研究:第十七部分。1型糖尿病患者糖尿病视网膜病变的14年发病率、进展情况及相关危险因素
Ophthalmology. 1998 Oct;105(10):1801-15. doi: 10.1016/S0161-6420(98)91020-X.
3
The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XXII the twenty-five-year progression of retinopathy in persons with type 1 diabetes.威斯康星糖尿病视网膜病变流行病学研究:XXII 1型糖尿病患者视网膜病变的25年进展情况
Ophthalmology. 2008 Nov;115(11):1859-68. doi: 10.1016/j.ophtha.2008.08.023.
4
The NEI-VFQ-25 in people with long-term type 1 diabetes mellitus: the Wisconsin Epidemiologic Study of Diabetic Retinopathy.长期1型糖尿病患者的NEI-VFQ-25:威斯康星糖尿病视网膜病变流行病学研究
Arch Ophthalmol. 2001 May;119(5):733-40. doi: 10.1001/archopht.119.5.733.
5
The Wisconsin Epidemiologic Study of Diabetic Retinopathy XXIII: the twenty-five-year incidence of macular edema in persons with type 1 diabetes.威斯康星糖尿病视网膜病变流行病学研究XXIII:1型糖尿病患者黄斑水肿的25年发病率
Ophthalmology. 2009 Mar;116(3):497-503. doi: 10.1016/j.ophtha.2008.10.016. Epub 2009 Jan 22.
6
The Wisconsin epidemiologic study of diabetic retinopathy: an update.
Aust N Z J Ophthalmol. 1990 Feb;18(1):19-22. doi: 10.1111/j.1442-9071.1990.tb00579.x.
7
The relation of retinal vessel caliber to the incidence and progression of diabetic retinopathy: XIX: the Wisconsin Epidemiologic Study of Diabetic Retinopathy.视网膜血管管径与糖尿病视网膜病变的发生率和进展的关系:第十九部分:威斯康星糖尿病视网膜病变流行病学研究
Arch Ophthalmol. 2004 Jan;122(1):76-83. doi: 10.1001/archopht.122.1.76.
8
How many steps of progression of diabetic retinopathy are meaningful? The Wisconsin epidemiologic study of diabetic retinopathy.糖尿病视网膜病变进展的多少个阶段是有意义的?威斯康星糖尿病视网膜病变流行病学研究。
Arch Ophthalmol. 2001 Apr;119(4):547-53. doi: 10.1001/archopht.119.4.547.
9
HLA-DR3 and DR4 and their relation to the incidence and progression of diabetic retinopathy.人类白细胞抗原-DR3和DR4及其与糖尿病视网膜病变发病率和进展的关系。
Ophthalmology. 2002 Feb;109(2):275-81. doi: 10.1016/s0161-6420(01)00925-3.
10
Digoxin does not accelerate progression of diabetic retinopathy.
Diabetes Care. 1995 Feb;18(2):237-40. doi: 10.2337/diacare.18.2.237.

引用本文的文献

1
Predicting Progression to Vision-Threatening Complications in Diabetic Retinopathy.预测糖尿病视网膜病变进展为威胁视力的并发症
Ophthalmol Sci. 2025 Jun 17;5(6):100859. doi: 10.1016/j.xops.2025.100859. eCollection 2025 Nov-Dec.
2
Gene Therapy in Diabetic Retinopathy and Diabetic Macular Edema: An Update.糖尿病视网膜病变和糖尿病性黄斑水肿的基因治疗:最新进展
J Clin Med. 2025 May 6;14(9):3205. doi: 10.3390/jcm14093205.
3
Vascular Perfusion Variability in Diabetic Retinopathy: A Sequential Interscan Optical Coherence Tomography Angiography Assessment.
糖尿病视网膜病变中的血管灌注变异性:序列扫描间光学相干断层扫描血管造影评估
J Clin Med. 2025 Mar 28;14(7):2312. doi: 10.3390/jcm14072312.
4
Association Between Hormone Levels and Retinopathy in Patients With Type 2 Diabetes: A Cross-Sectional Study.2型糖尿病患者激素水平与视网膜病变的关联:一项横断面研究。
Transl Vis Sci Technol. 2025 Feb 3;14(2):17. doi: 10.1167/tvst.14.2.17.
5
Beyond VEGF: Angiopoietin-Tie Signaling Pathway in Diabetic Retinopathy.超越血管内皮生长因子:糖尿病视网膜病变中的血管生成素-Tie信号通路
J Clin Med. 2024 May 9;13(10):2778. doi: 10.3390/jcm13102778.
6
Socioeconomic Disparities and Emergency Department Visits for Diabetic Retinopathy in California.加利福尼亚州糖尿病视网膜病变的社会经济差异与急诊就诊情况
J Vitreoretin Dis. 2024 Feb 26;8(3):293-298. doi: 10.1177/24741264241234132. eCollection 2024 May-Jun.
7
Use of Diabetes Technologies and Retinopathy in Adults With Type 1 Diabetes.糖尿病技术的应用与 1 型糖尿病成人患者的视网膜病变
JAMA Netw Open. 2024 Mar 4;7(3):e240728. doi: 10.1001/jamanetworkopen.2024.0728.
8
Evaluation of the effect of intravitreal injections on corneal epithelial, scleral and limbal region changes in diabetic retinopathy by AS-OCT.通过光学相干断层扫描血管造影(AS-OCT)评估玻璃体内注射对糖尿病性视网膜病变患者角膜上皮、巩膜和角膜缘区域变化的影响。
Int Ophthalmol. 2024 Feb 8;44(1):31. doi: 10.1007/s10792-024-02947-8.
9
Aspirin intake is not associated with diabetic retinopathy and diabetic macular edema: A report from the Fushun diabetic retinopathy cohort study.阿司匹林摄入与糖尿病性视网膜病变和糖尿病性黄斑水肿无关:来自抚顺糖尿病视网膜病变队列研究的报告。
Indian J Ophthalmol. 2024 Feb 1;72(Suppl 2):S298-S302. doi: 10.4103/IJO.IJO_2932_23. Epub 2024 Jan 25.
10
The Diabetic Retinopathy "Pandemic" and Evolving Global Strategies: The 2023 Friedenwald Lecture.糖尿病视网膜病变“大流行”与不断演变的全球策略:2023年弗里登瓦尔德讲座
Invest Ophthalmol Vis Sci. 2023 Dec 1;64(15):47. doi: 10.1167/iovs.64.15.47.